Jilin Province Xidian Pharmaceutical Sci-Tech Development Co (SZSE:301130) Future 3-5Y EPS without NRI Growth Rate : N/A (As of May. 28, 2025)

View and export this data going back to 2022. Start your Free Trial

What is Jilin Province Xidian Pharmaceutical Sci-Tech Development Co Future 3-5Y EPS without NRI Growth Rate?

Future 3-5Y EPS without NRI Growth Rate is the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

As of today, Jilin Province Xidian Pharmaceutical Sci-Tech Development Co's Future 3-5Y EPS without NRI Growth Rate is N/A.

Competitive Comparison of Jilin Province Xidian Pharmaceutical Sci-Tech Development Co's Future 3-5Y EPS without NRI Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Jilin Province Xidian Pharmaceutical Sci-Tech Development Co's Future 3-5Y EPS without NRI Growth Rate, along with its competitors' market caps and Future 3-5Y EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Jilin Province Xidian Pharmaceutical Sci-Tech Development Co's Future 3-5Y EPS without NRI Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Jilin Province Xidian Pharmaceutical Sci-Tech Development Co's Future 3-5Y EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Jilin Province Xidian Pharmaceutical Sci-Tech Development Co's Future 3-5Y EPS without NRI Growth Rate falls into.

Save Embed

;

Save Embed

;

Jilin Province Xidian Pharmaceutical Sci-Tech Development Co (SZSE:301130) Future 3-5Y EPS without NRI Growth Rate Explanation

Future 3-5Y EPS without NRI Growth Rate s the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average earnings per share (EPS) estimates growth rate.

Jilin Province Xidian Pharmaceutical Sci-Tech Development Co Future 3-5Y EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of Jilin Province Xidian Pharmaceutical Sci-Tech Development Co's Future 3-5Y EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Jilin Province Xidian Pharmaceutical Sci-Tech Development Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jilin Province Xidian Pharmaceutical Sci-Tech Development Co Ltd (SZSE:301130) » Definitions » Future 3-5Y EPS without NRI Growth Rate

Traded in Other Exchanges

N/A

Address

No. 777, Xidian Street, Panshi Economic Development Zone, Jilin Province, Panshi, CHN, 132300

Website

http://www.xidianyy.com

Jilin Province Xidian Pharmaceutical Sci-Tech Development Co Ltd is mainly engaged in the research, development, production, and sales of chemical APIs and preparations. It is focused on the development and manufacturing of iron supplement preparations, circulatory disorder treatment drugs, anti-psychotic drugs, and APIs. The company's product portfolio comprises Compound Ferrous Sulfate Folic Acid Tablets, Risperidone Orally Disintegrating Tablets, Escitalopram Oxalate Tablets, Daphne Capsules, Zoledronic Acid for Injection, etc., and various APIs.

Jilin Province Xidian Pharmaceutical Sci-Tech Development Co Headlines

No Headlines